Hester Biosciences Limited (NSE:HESTERBIO)
India · Delayed Price · Currency is INR 2,212.80
-29.00 (-1.29%)
Sep 24, 2026, 12:55 PM IST
Hester Biosciences Market Cap
Hester Biosciences has a market cap or net worth of 19.11 billion as of September 23, 2026. Its market cap has increased by 13.85% in one year.
Market Cap
19.11B
Enterprise Value
21.07B
Revenue
3.27B
Ranking
n/a
PE Ratio
14.03
Stock Price
2,212.80
ChartMarket Cap Chart
Since October 11, 1996, Hester Biosciences's market cap has increased from 22.04M to 19.11B, an increase of 86,579.74%. That is a compound annual growth rate of 25.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 19.11B | 41.10% |
| Dec 31, 2025 | 13.54B | -33.49% |
| Dec 31, 2024 | 20.36B | 64.06% |
| Dec 29, 2023 | 12.41B | -18.54% |
| Dec 30, 2022 | 15.24B | -29.34% |
| Dec 31, 2021 | 21.56B | 48.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 46.35B |
| Solara Active Pharma Sciences | 35.80B |
| Ind-Swift Laboratories | 32.46B |
| Sakar Healthcare | 26.25B |
| Indoco Remedies | 23.78B |
| Windlas Biotech | 22.89B |
| Beta Drugs | 20.83B |
| Jagsonpal Pharmaceuticals | 15.06B |